Compare INCY & TSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INCY | TSCO |
|---|---|---|
| Founded | 1991 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0B | 19.3B |
| IPO Year | 1994 | 1996 |
| Metric | INCY | TSCO |
|---|---|---|
| Price | $95.67 | $30.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 22 |
| Target Price | ★ $103.52 | $53.05 |
| AVG Volume (30 Days) | 1.3M | ★ 12.9M |
| Earning Date | 04-28-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 2.76% |
| EPS Growth | ★ 4173.33 | 0.98 |
| EPS | ★ 1.47 | 0.31 |
| Revenue | $3,394,635,000.00 | ★ $15,524,046,000.00 |
| Revenue This Year | $10.44 | $7.32 |
| Revenue Next Year | $10.99 | $6.01 |
| P/E Ratio | ★ $66.63 | $98.53 |
| Revenue Growth | ★ 13.67 | 4.31 |
| 52 Week Low | $62.84 | $29.42 |
| 52 Week High | $112.29 | $63.99 |
| Indicator | INCY | TSCO |
|---|---|---|
| Relative Strength Index (RSI) | 45.80 | 20.79 |
| Support Level | $93.17 | N/A |
| Resistance Level | $102.07 | $56.04 |
| Average True Range (ATR) | 3.23 | 1.11 |
| MACD | -0.14 | -0.00 |
| Stochastic Oscillator | 28.77 | 14.58 |
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,395 of its namesake banners in 49 states, along with 207 Petsense by Tractor Supply stores. Stores are generally concentrated in rural communities rather than urban and suburban areas. In fiscal 2025, revenue consisted primarily of livestock, equine & agriculture (around 30%), companion animal (25%), and seasonal & recreation (around 25%).